← Back to Clinical Trials
Recruiting NCT07151534

NCT07151534 Body Awareness, Trunk Stability, and Arm Function in MS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07151534
Status Recruiting
Phase —
Sponsor Hacettepe University
Condition Multiple Sclerosis
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-08-06
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-08-06 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the relationship between body awareness, trunk stabilization, and upper extremity functionality in patients with Multiple Sclerosis (MS). Hypotheses of the study: H1: There is a significant relationship between body awareness and upper extremity functionality in patients with MS. H2: There is a significant relationship between body awareness and trunk stabilization in patients with MS. H3: Body awareness is reduced in patients with MS compared to healthy individuals. H4: Trunk stabilization is reduced in patients with MS compared to healthy individuals. H5: Upper extremity functionality is reduced in patients with MS compared to healthy individuals.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with Multiple Sclerosis (MS) by a neurologist according to the McDonald criteria * Aged 18 years or older * Expanded Disability Status Scale (EDSS) score ≤ 5 * Mini-Mental State Examination (MMSE) score ≥ 24 * A control group consisting of healthy individuals matched with MS patients in terms of age and sex Exclusion Criteria: * Having a neurological disorder other than MS * Having experienced a relapse and/or used corticosteroids in the past 3 months * Having an orthopedic/systemic condition affecting the upper extremities or trunk * Being pregnant * Refusing to participate or not providing written informed consent * Healthy individuals who have an orthopedic/systemic condition affecting the upper extremities or trunk, who are pregnant, or who do not agree to participate and provide written informed consent will be excluded.

Contact & Investigator

Central Contact

Güngör Beyza Özvar Şenöz

✉ beyzaozvar@gmail.com

📞 5053888617

Principal Investigator

Muhammed Kılınç

PRINCIPAL INVESTIGATOR

Hacettepe University

Frequently Asked Questions

Who can join the NCT07151534 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07151534 currently recruiting?

Yes, NCT07151534 is actively recruiting participants. Contact the research team at beyzaozvar@gmail.com for enrollment information.

Where is the NCT07151534 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07151534 clinical trial?

NCT07151534 is sponsored by Hacettepe University. The principal investigator is Muhammed Kılınç at Hacettepe University. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology